{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:01:51Z","timestamp":1788454911358,"version":"build-2803163510"},"reference-count":47,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"unspecified","delay-in-days":66,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2020,8,2]]},"DOI":"10.1080\/14760584.2020.1800458","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T19:47:48Z","timestamp":1596138468000},"page":"771-779","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Safety profile of <i>Infanrix hexa<\/i> \u2013 17 years of GSK\u2019s passive post-marketing surveillance"],"prefix":"10.1080","volume":"19","author":[{"given":"Ivonne","family":"Puente G\u00f3mez","sequence":"first","affiliation":[{"name":"GSK, Wavre, Belgium"},{"name":"AstraZeneca, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Verheust","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hanssens","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"},{"name":"Miltenyi Biomedicine, Bergisch Gladbach, North Rhine-Westphalia, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0082-9375","authenticated-orcid":false,"given":"Jan","family":"Dolhain","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"},{"name":"Danone Benelux, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12444"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.32"},{"key":"cit0003","unstructured":"European Medicines Agency. Infanrix hexa product information. [Cited 2018 Oct 16]. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/infanrix-hexa-epar-product-information_en.pdf"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1045-1870(03)00033-5"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.1.e12"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00230-4"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1086\/375820"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26269"},{"issue":"4","key":"cit0009","first-page":"146","volume":"39","author":"Bonanni P","year":"2015","journal-title":"Epidemiol Prev"},{"issue":"2","key":"cit0010","volume":"68","author":"Paradowska-Stankiewicz I","year":"2014","journal-title":"Przegl Epidemiol"},{"key":"cit0011","unstructured":"European Centre for Disease Prevention and Control. Pertussis. ECDC. Annual Epidemiological Report for 2016. [Cited 2019 Dec 4]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/portal\/files\/documents\/AER-for-2016-pertussis.pdf"},{"key":"cit0012","unstructured":"European Medicines Agency. Infanrix hexa: procedural steps taken and scientific information after the authorisation. [Cited 2019 Nov 19]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/procedural-steps-after\/infanrix-hexa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"},{"key":"cit0013","unstructured":"European Medicines Agency. Prevenar 13 product information. [Cited 2019 July 1]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/prevenar-13-epar-product-information_en.pdf"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.068"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3918"},{"key":"cit0016","unstructured":"The Information System of the Federal Health Monitoring. Data from germany data sources of the federal statistical office. Statistics on the causes of death. Infant deaths (from 1998). [Cited Nov 2017]. Available from: http:\/\/www.gbe-bund.de\/gbe10\/pkg_isgbe5.prc_isgbe?p_uid=&p_aid=&p_sprache=E"},{"key":"cit0017","unstructured":"Centraal Bureau voor de Statistiek (CBS). Central bureau of statistics website. Themes. Health and welfare. Figures. Deaths by main primary cause of death & themes. [Cited Nov 2017]. Available from: https:\/\/www.cbs.nl\/en-gb\/society\/health-and-welfare"},{"key":"cit0018","unstructured":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM). Centre d\u2019Epidemiologie sur les causes M\u00e9dicales de d\u00e9c\u00e8s (C\u00e9piDc) - causes m\u00e9dicales de d\u00e9c\u00e8s. [Cited Nov 2017]. Available from: http:\/\/www.cepidc.inserm.fr\/"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116479"},{"key":"cit0020","unstructured":"European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). Good practice guide on recording, coding, reporting and assessment of medication errors (EMA\/762563\/2014). [Cited 2019 Nov 19]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/good-practice-guide-recording-coding-reporting-assessment-medication-errors_en.pdf"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80007-6"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003"},{"key":"cit0023","unstructured":"European Medicines Agency. ICH guideline E2C (R2) on periodic benefit-risk evaluation report (PBRER). [Cited 2019 Oct 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-0.pdf"},{"key":"cit0024","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), et al. Providing postmarketing periodic safety reports in the ICH E2C(R2) format (Periodic benefit-risk evaluation report): guidance for industry. [Cited 2019 Oct 18]. Available from: https:\/\/www.fda.gov\/media\/85520\/download"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2185"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ423"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4141"},{"key":"cit0028","volume-title":"Immunization safety review: vaccinations and sudden unexpected death in infancy","author":"Institute of Medicine (US) Immunization Safety Review Committee","year":"2003"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-4171"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-015-0318-7"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.07.027"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.03.055"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-004-1594-7"},{"key":"cit0034","unstructured":"World Health Organization. Global vaccine safety: six common misconceptions about immunization. [Cited 2019 Dec 4]. Available from: https:\/\/www.who.int\/vaccine_safety\/initiative\/detection\/immunization_misconceptions\/en\/index4.html"},{"key":"cit0035","unstructured":"Centers for Disease Control and Prevention. Vaccines and sudden infant death syndrome (SIDS). [Cited 2019 Dec 4]. Available from: https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/sids.html#rel"},{"key":"cit0036","unstructured":"European Medicines Agency. EMA public statement: EMA update on hexavalent vaccines: hexavac and Infanrix hexa. [Cited 2018 Oct 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/public-statement\/european-medicines-agency-public-statement-update-hexavalent-vaccines-hexavac-infanrix-hexa_en.pdf"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1542\/pir.33-7-314"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2016.3345"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb01960.x"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1383157"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.039"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2146"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.068"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.081"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.07.003"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.3201\/eid2510.190271"},{"issue":"6","key":"cit0047","first-page":"53","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1800458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:52:01Z","timestamp":1629208321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2020.1800458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,2]]}},"alternative-id":["10.1080\/14760584.2020.1800458"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2020.1800458","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}